HSV-2 gD Antibodies

Santa Cruz Biotechnology features a diverse variety of HSV-2 gD monoclonal antibodies for research focused on understanding glycoprotein D in herpes simplex virus type 2. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein D is a critical component of the HSV-2 envelope, playing a vital role in viral entry and infection by mediating the virus's interaction with host cell receptors. Understanding HSV-2 gD function is essential for developing therapeutic strategies and vaccines against herpes simplex virus infections. The study of HSV-2 gD also contributes to the broader understanding of viral pathogenesis and immune evasion mechanisms. Researchers can explore viral entry mechanisms, track protein expression patterns, and investigate host-pathogen interactions through various experimental approaches. Advanced research techniques enable detailed analysis of HSV-2 gD localization, expression levels, and protein-protein interactions. HSV-2 gD monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge of viral infections and potential therapeutic interventions.